BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240429
DTEND;VALUE=DATE:20240503
DTSTAMP:20260515T225229
CREATED:20231124T115148Z
LAST-MODIFIED:20231124T115309Z
UID:38225-1714348800-1714694399@www.pharmajournalist.com
SUMMARY:3rd LNP Formulation & Process Development Summit
DESCRIPTION:Following the success of the first 2 years of the LNP Formulation & Process Development Summit\, we are hugely excited to announce the much-anticipated return of this world-leading summit in 2024. \nThis April\, the 3rd LNP Formulation & Process Development Summit returns to Boston\, bringing together over 400 experts in LNP Biology\, Chemistry\, Formulation\, Analytical Development\, Process Development\, Manufacturing and more. This is your ultimate platform for sharing insights\, learning new concepts and networking to propel more LNPs into the clinic in 2024. \nJoin the ever-growing community of LNP pioneers as they tackle the challenges associated with developing safe\, compliant and efficacious LNPs\, to treat a variety of disease indications at a variety of target organs. This starts with the in vitro discovery of LNPs through to the manufacturing processes\, with end-to-end synergy fundamental. \nHear from industry powerhouses Pfizer\, Moderna\, Alnylam and more\, as well as new companies to share their insights to this community including Capstan Therapeutics\, AbbVie\, Mana Bio\, Serina Therapeutics\, Karma Biotechnologies and more. \nWith an expanded content offering and a 4-track\, 4-day summit format\, we continue to be the most comprehensive\, premium LNP content available to industry. Part of this year’s content growth\, the addition of the ‘LNP IP & Commercial Partnerships Focus Day’ has evolved with the current industry trends to secure long standing partnership to demonstrate clinical results\, as well as gaining a further handle on the current IP and legal landscape. \nTo know more visit: https://ter.li/s96la3
URL:http://www.pharmajournalist.com/event/3rd-lnp-formulation-process-development-summit/
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR